GeoHealth: Geographic Information System for Health Management and Clinical, Epidemiological and Translational Research

NCT ID: NCT05637411

Last Updated: 2022-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

214 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-09

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the project is to develop a potentially marketable system for clinical, epidemiological and translational research capable of associating contextual variables and geospatial data with clinical patient information. The GeoHealth system will include a section to perform exploratory analysis that will help identify risk factors to optimize clinical decision making. The system will be used in a study of the influence of environmental factors in more than 800,000 asthmatic patients in the region of Andalucía, Spain. The results of this study will help to develop predictive models of risk of exacerbation in asthma patients. Currently, disease management guidelines state that asthma control has two components: current disease control and future risk of exacerbations. These two components are key when assessing disease management, following a stepwise model that seeks to improve current control and minimize future risk. However, although the current control of the disease is defined and has established methodologies for its measurement (Asthma Control Test -ACT- and Asthma Control Questionnaire -ACQ-), the risk of suffering exacerbations is not yet a measurable component.

Therefore, these predictive models could help in professional decision making for asthmatic patients.

The predictive models will be validated prospectively and implemented in a decision support system for the management of asthmatic patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The GeoHealth system will be designed as a modular platform that will allow communication to import patient data from EHR systems and research platforms through the ISO13606 and CDISC ODM standards. Furthermore, integrations will be made with the Andalusian HCE (Diraya) systems and the REDCap and OpenClinica clinical trial management systems.

GeoHealth integrates a set of heterogeneous open data sources, allowing a visualization, on the same map, of the clinical and contextual data of each patient based on their usual location (Census region of their home) and the desired date of the study. The data integrated into the system provide demographic information and the environmental conditions associated with the location of the patient.

The system has a module that perform analysis that can range from simple correlations between variables to other more complex analyzes such as clustering analysis, linear and logistic regressions and others.

Once the models that will be applied in decision-making have been determined, a study will be carried out on the degree of alignment between the recommendations established by the models and the clinical decision adopted by the professionals. The study will be performed during a period of 12 months in patients treated in the clinical centers that participate in this project.

The data come from different sources and all have been integrated into the same representation system. Using the free mapping system "OpenStreetMap" and the "Plotly" Python library, both the demographic data of the patients and their contextual variables are represented in a Dashboard, containing a single map.

The system offers the possibility to deploy different heat-maps using different regions (Census Regions, Postal Code Regions and Health Districts) and different demographic variables for each type of region (Population density, percentage of males and females, average incomes…etc.). Moreover, it is possible to choose between the different regions of Andalucía and a range of dates for the environmental (Pollution, pollen and meteorological data) and patient's data. Other places locations are deployed on the map as hospitals, clinics, roads and parks.

The system provides an advance in the deployment, observation and analysis for the health sector. It allows clinical researchers to understand better how the patient is affected by his environment and perform analysis to discover patterns in the data.

Other systems such as Transmart or i2b2, enable sharing, integration, standardization, and analysis of heterogeneous data from healthcare and translational research. GeoHealth has been presented as a possible extension of these two platforms helping them to incorporate the possibility to include geospatial data in the analysis.

Moreover, the system is going to be used and tested in two projects than aim to analyze the prevalence of asthmatic patients in the Macarena Hospital's area (Sevilla, Spain) and another in the region of Andalucía (Spain) where more than 800.000 patients will be analyzed.

It has been demonstrated how decisive the patient's environment is in the development of many diseases. GeoHealth has been presented as a platform that allows clinical researchers in the observation and analysis task to understand better how the environment affect them.

Moreover, the performed extraction, processing and integration of the open-data in the system and the intuitive deployment on a single map allow researchers to save time and access advanced analysis techniques that can be performed without the knowledge necessary to develop the algorithms that form them.

All these aspects make GeoHealth an innovative platform with a potential impact on the development of clinical studies related to the location and environment of the patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma Allergy Heart Diseases Obesity Rheumatic Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Retrospective cohort

The clinical data, socioeconomical data and environmental exposure data from 800.000 asthmatic patients attended in our region from 2007 to 2021 will be analysed to train and validate a risk predictive model for exacerbation (defined as emergency visits)

Predictive model

Intervention Type OTHER

We will define and validate predictive models of risk of exacerbations in asthmatic patients

Prospective cohort

The same inclusion/exclusion criteria were applied prospectively. This is an external validation cohort.

Predictive model

Intervention Type OTHER

We will define and validate predictive models of risk of exacerbations in asthmatic patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Predictive model

We will define and validate predictive models of risk of exacerbations in asthmatic patients

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with bornchial asthma.

Exclusion Criteria

* Women who are pregnant, breastfeeding or want to become pregnant during the duration of the study.
* Subjects with malignant disease, uncontrolled risk factors or any pathology that compromises the safety of the study.
* Subjects with problems that limit their ability to cooperate.
Minimum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Universitario Virgen Macarena

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alberto Moreno Conde

PHD Alberto Moreno Conde

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alberto Moreno

Role: PRINCIPAL_INVESTIGATOR

Hospital Universitario Virgen Macarena

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alberto Moreno Conde

Seville, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI19/01092

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.